We are live on
!
Find out more
Brown Advisory Portfolio holdings
AUM
$60.9B
1-Year Est. Return
15.24%
This Fund
S&P 500
This Quarter
Est. Return
+6.6%
1 Year Est. Return
+15.24%
3 Year Est. Return
+71.23%
5 Year Est. Return
+86.65%
10 Year Est. Return
+447.92%
AUM
$29.1B
AUM Growth
+$628M
(+2.2%)
Cap. Flow
-$702M
Cap. Flow
% of AUM
-2.41%
Top 10 Holdings %
Top 10 Hldgs %
22.73%
Holding
1,138
New
91
Increased
498
Reduced
344
Closed
68
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$407M |
| 2 |
DexCom
DXCM
|
+$326M |
| 3 |
Roper Technologies
ROP
|
+$288M |
| 4 |
PayPal
PYPL
|
+$238M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$106M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$498M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$448M |
| 3 |
Fastenal
FAST
|
+$296M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$175M |
| 5 |
Amazon
AMZN
|
+$105M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.26% |
| 2 | Healthcare | 14.35% |
| 3 | Financials | 13.74% |
| 4 | Consumer Discretionary | 12.34% |
| 5 | Communication Services | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Enterprise Products Partners
EPD
$83.2B
| $7.29M | 0.03% |
263,847
+2,701
| +1% | +$74.6K |
|
327
Delta Air Lines
DAL
$58.7B
| $7.25M | 0.02% |
184,260
+1,152
| +0.6% | +$43.6K |
|
328
Air Products & Chemicals
APD
$65.8B
| $7.18M | 0.02% |
51,632
-1,296
| -2% | -$180K |
|
329
Arthur J. Gallagher & Co
AJG
$67B
| $7.13M | 0.02% |
140,141
+930
| +0.7% | +$45.9K |
|
|
PFPT
330
DELISTED
Proofpoint, Inc.
PFPT
| $7.07M | 0.02% |
94,394
+7,850
| +9% | +$579K |
|
331
Addus HomeCare
ADUS
$2.22B
| $7.01M | 0.02% |
267,925
+2,311
| +0.9% | +$50.8K |
|
332
Walker & Dunlop
WD
$1.74B
| $6.99M | 0.02% |
276,555
+1,000
| +0.4% | +$25.4K |
|
333
MGP Ingredients
MGPI
$400M
| $6.97M | 0.02% |
172,091
+13,705
| +9% | +$530K |
|
334
Donaldson
DCI
$11.1B
| $6.93M | 0.02% |
185,688
+13
| +0% | +$473 |
|
335
Blackrock
BLK
$170B
| $6.8M | 0.02% |
18,765
-89
| -0.5% | -$32.4K |
|
336
Omeros
OMER
$798M
| $6.56M | 0.02% |
587,508
+43,745
| +8% | +$499K |
|
337
Diageo
DEO
$49.2B
| $6.54M | 0.02% |
56,319
+10,880
| +24% | +$1.24M |
|
338
Capri Holdings
CPRI
$1.88B
| $6.49M | 0.02% |
138,789
-26,488
| -16% | -$1.32M |
|
|
RDS.A
339
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $6.4M | 0.02% |
127,808
+4,082
| +3% | +$208K |
|
340
BorgWarner
BWA
$12.9B
| $6.37M | 0.02% |
205,668
-26,183
| -11% | -$772K |
|
341
Incyte
INCY
$25.8B
| $6.25M | 0.02% |
66,248
-856
| -1% | -$72.1K |
|
|
P
342
Everpure Inc
P
$24B
| $6.22M | 0.02% |
458,753
| – | – |
|
|
DEST
343
DELISTED
Destination Maternity Corporation
DEST
| $6.21M | 0.02% |
875,274
+3,305
| +0.4% | +$19.3K |
|
344
Phillips 66
PSX
$82.9B
| $6.09M | 0.02% |
75,637
-1,746
| -2% | -$136K |
|
345
Eli Lilly
LLY
$1.09T
| $6.02M | 0.02% |
75,032
+744
| +1% | +$59.6K |
|
346
NextEra Energy
NEE
$186B
| $5.96M | 0.02% |
194,744
+16,852
| +9% | +$531K |
|
347
Aflac
AFL
$65.6B
| $5.95M | 0.02% |
165,682
+2,112
| +1% | +$76.9K |
|
|
APC
348
DELISTED
Anadarko Petroleum
APC
| $5.9M | 0.02% |
93,170
+8,163
| +10% | +$455K |
|
349
Union Pacific
UNP
$176B
| $5.89M | 0.02% |
60,399
+1,624
| +3% | +$152K |
|
350
iShares Core S&P Mid-Cap ETF
IJH
$123B
| $5.8M | 0.02% |
187,320
+4,785
| +3% | +$148K |
|
Similar funds
QCM
Brown Advisory's Q3 2016 Portfolio in Review
As of Q3 2016, Brown Advisory held 1,138 positions worth $29.1B, up 2.2% from $28.5B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Brown Advisory's Q3 2016 filing shows 91 new, 498 increased, 344 reduced and 68 closed positions. Its largest new stake was Fortive: 12,666,674 shares worth $407M. The largest sale was Bristol-Myers Squibb, an estimated $498M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
- Brown Advisory's largest Q3 2016 buy was Fortive: 12,666,674 shares worth $407M.
- Brown Advisory added most to DexCom in Q3 2016, an estimated $326M increase.
- Brown Advisory's biggest Q3 2016 reduction was Bristol-Myers Squibb, cutting an estimated $498M.
- Brown Advisory fully exited DIAMOND RESORTS INTL, INC in Q3 2016, selling an estimated $53.1M.
- Brown Advisory's ten largest holdings make up 23% of its $29.1B portfolio in Q3 2016.
- Brown Advisory opened 91 new positions and closed 68 in Q3 2016.
- Brown Advisory's portfolio value rose 2.2% quarter-over-quarter to $29.1B.
Based on Brown Advisory's 13F filing for Q3 2016, filed 14 Nov 2016.